CORPORATE INTEGRITY AGREEMENT BETWEEN THECorporate Integrity Agreement • September 26th, 2019
Contract Type FiledSeptember 26th, 2019Avanir Pharmaceuticals, Inc. (Avanir) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United States Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) (Federal health care program requirements) and with the statutes, regulations, and written directives of the Food and Drug Administration (FDA requirements). Contemporaneously with this CIA, Avanir is entering into a Settlement Agreement with the United States. Avanir is also entering into settlement agreements with various states (State Settlement Agreements) and Avanir’s agreement to this CIA is a condition precedent to those agreements.